Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Lyme disease

Not recruiting

Registered drug

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
Substances:Sodium Chloride Solution 0.9%

Contact Research Centre

Obesity+1

Not recruiting

Investigational

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Envudeucitinib

Contact Research Centre

Obesity

Not recruiting

Investigational

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Registered drug

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Osteoporosis postmenopausal

Not recruiting

Investigational

Study on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:AGA2118

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ly4100511

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Find therapies in clinical trials near you – page 8

229 trials match your criteria

Escherichia infection

Study on the Safety and Immune Response of JNJ-78901563 and High-dose Influenza Vaccine in Preventing E. coli Infections in Adults Aged 65 and Older

Respiratory syncytial virus infection+3

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Lyme disease

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Obesity+1

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Psoriasis

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Obesity

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Sjogren's syndrome

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Psoriasis

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Psoriatic arthropathy

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Osteoporosis postmenopausal

Study on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis

Psoriasis

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Psoriatic arthropathy

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.